🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
GSK159802 is a potent, inhaled, long acting selective beta-2-receptor agoni...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-08-24
Trial ID
NCT00364273
Treatments Being Tested
This study aims to compare the efficacy of three therapies for chronic obst...
Status
Unknown
Location
The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
Start Date
2017-05
Trial ID
NCT03169504
Treatments Being Tested
The purpose of this study is to demonstrate the pharmacodynamic bioequivale...
Status
Completed
Location
Combined Research Orlando
Start Date
2018-10-17
Trial ID
NCT03394989
This study is designed to provide data about the 24 hours FEV1 profile, saf...
Status
Completed
Location
Novartis Investigator Site
Start Date
2007-11
Trial ID
NCT00557440
To compare the efficacy and safety profiles of Fluticasone Propionate 100 m...
Status
Unknown
Location
Multiple Locations
Start Date
2018-10
Trial ID
NCT03562923
Treatments Being Tested
Bioequivalence study between two inhaler products of fixed dose combination...
Status
Completed
Location
BECRO Clinical Facility
Start Date
2018-11-20
Trial ID
NCT03751202
Treatments Being Tested
The purpose of the study is to determine the appropriate dose of fluticason...
Status
Completed
Location
Research Site
Start Date
2006-11
Trial ID
NCT00403286
This study compared the 14-day bronchodilator efficacy of indacaterol with ...
Status
Completed
Location
Novartis Investigator Site
Start Date
2010-03
Trial ID
NCT01089127
Treatments Being Tested
This trial is a randomized, double-blind, parallel-group, multicenter study...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-04-30
Trial ID
NCT01110200
Treatments Being Tested
Bioequivalence study between two inhaler products of fixed dose combination...
Status
Completed
Location
BECRO Clinical Facility
Start Date
2020-09-22
Trial ID
NCT04564456